Gene editing has emerged as a powerful approach for targeting the genetic causes of disease, but getting the editing ...

Two papers published in The New England Journal of Medicine highlight the potential of gene editing for treatment of sickle ...

The gene editing treatment targets the relatively common 1717-1G>A splicing mutation, which does not respond to many current ...

A new platform identifies which genes drive particle assembly to engineer cells that yield more potent delivery vehicles.

How do our genes determine our appearance and our susceptibility to disease? This question is central to biomedical research, ...

India has developed BIRSA 101, its first indigenous CRISPR gene therapy for sickle cell disease, using a more precise ...

Learn about the groundbreaking gene therapy for sickle cell disease at Manning Family Children's Hospital in Louisiana, ...

Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, ...

Diabetes mellitus affects more than 500 million people worldwide, and both Type 1 (T1D) and Type 2 (T2D) forms converge on a common endpoint: the loss or ...

That is because scientists keen to achieve more precise control over an organism’s genetics are experimenting with a ...

Most gene-editing tools cut DNA wherever they’re pointed, with no way to tell a tumor cell from a healthy one. A study ...